IE782175L - Carnitine derivatives in pharmaceutical formulations - Google Patents

Carnitine derivatives in pharmaceutical formulations

Info

Publication number
IE782175L
IE782175L IE217578A IE217578A IE782175L IE 782175 L IE782175 L IE 782175L IE 217578 A IE217578 A IE 217578A IE 217578 A IE217578 A IE 217578A IE 782175 L IE782175 L IE 782175L
Authority
IE
Ireland
Prior art keywords
pharmaceutical formulations
carnitine derivatives
carnitine
derivatives
formulations
Prior art date
Application number
IE217578A
Other versions
IE51711B1 (en
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT51663/77A external-priority patent/IT1143611B/en
Priority claimed from IT4767678A external-priority patent/IT1155772B/en
Priority claimed from IT4789978A external-priority patent/IT1155814B/en
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IE1850/85A priority Critical patent/IE51712B1/en
Publication of IE782175L publication Critical patent/IE782175L/en
Publication of IE51711B1 publication Critical patent/IE51711B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE217578A 1977-11-03 1978-11-03 Carnitine derivatives IE51711B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1850/85A IE51712B1 (en) 1977-11-03 1978-11-03 Pharmaceutical compositions containing carnitine derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT51663/77A IT1143611B (en) 1977-11-03 1977-11-03 APPLICATION OF ACETYL-CARNITINE IN THE THERAPY OF CARDIAC AFFECTIONS OF / ANOXIC, ISCHEMIC, CARDIOTOXIC AND IN ARITHMIC SYNDROMES
IT4767678A IT1155772B (en) 1978-01-18 1978-01-18 Acylated L-carnitine derivs. - useful for treating myocardial anoxia, ischaemia, arrhythmic syndromes, cardiac insufficiencies, etc.
IT4789978A IT1155814B (en) 1978-02-03 1978-02-03 Acylated L-carnitine derivs. - useful for treating myocardial anoxia, ischaemia, arrhythmic syndromes, cardiac insufficiencies, etc.

Publications (2)

Publication Number Publication Date
IE782175L true IE782175L (en) 1979-05-03
IE51711B1 IE51711B1 (en) 1987-03-04

Family

ID=27273641

Family Applications (1)

Application Number Title Priority Date Filing Date
IE217578A IE51711B1 (en) 1977-11-03 1978-11-03 Carnitine derivatives

Country Status (2)

Country Link
GB (1) GB2008578A (en)
IE (1) IE51711B1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
IT1299544B1 (en) * 1998-07-03 2000-03-16 Sigma Tau Ind Farmaceuti SOLID COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION INCLUDING NON-HYGROSCOPIC SALTS OF L-CARNITINE AND L-CARNITINE ALCANOYLS
CA2352485A1 (en) * 1998-11-26 2000-06-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia
US8334132B2 (en) 2006-11-09 2012-12-18 Mitsubishi Rayon Co., Ltd. Process for production of a betaine such as carnitine
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
HUE032165T2 (en) 2011-04-13 2017-09-28 Thermolife Int Llc N-acetyl beta alanine methods of use
AU2021377897A1 (en) 2020-11-12 2024-09-12 Thermolife International, Llc Methods of increasing blood oxygen saturation
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
KR20230145103A (en) 2021-02-11 2023-10-17 써모라이프 인터내셔널, 엘엘씨 Method of administering nitric oxide gas

Also Published As

Publication number Publication date
IE51711B1 (en) 1987-03-04
GB2008578A (en) 1979-06-06

Similar Documents

Publication Publication Date Title
KE3223A (en) Pharmaceutical compositions containing carnitine derivatives
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
NZ186965A (en) Guanidino derivatives and pharmaceutical compositions
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ186189A (en) M-trifluoromethyl phenylpiderazine derivatives and pharmaceutical compositions
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
ZA804196B (en) Pharmaceutical formulations
NZ189246A (en) 4-spectinomycylamine its salts and pharmaceutical compositions
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ186119A (en) 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ187876A (en) Tetraline derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ188101A (en) N-substituted-2-aminobenzoic acid derivatives and pharmaceutical compositions
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions
GB2010261B (en) Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them
NZ187965A (en) 2-cyclopropylchromone derivatives and pharmaceutical compositions